Trial of selepressin for treatment of septic shock begins
17 August 2015 | By Victoria White
Ferring Pharmaceuticals has started patient enrollment in a Phase 2b/3 clinical trial of selepressin for the treatment of septic shock...
List view / Grid view
17 August 2015 | By Victoria White
Ferring Pharmaceuticals has started patient enrollment in a Phase 2b/3 clinical trial of selepressin for the treatment of septic shock...
17 August 2015 | By Victoria White
The ISS has recommended that Mylan shareholders vote "against" the unsolicited offer to acquire all of the outstanding shares of Perrigo...
17 August 2015 | By Victoria White
The number of people living with diabetes in the UK has soared by nearly 60% in a decade, according to a new analysis by Diabetes UK...
17 August 2015 | By Victoria White
In Roche’s large pivotal Phase II study, BIRCH, atezolizumab met its primary endpoint and shrank tumours in people with locally advanced or metastatic NSCLC...
13 August 2015 | By Katie Sadler, Digital Content Producer, European Pharmaceutical Review
Roche has announced the acquisition of GeneWEAVE BioSciences Inc. to strengthen its offering in the field of microbiology diagnostics.
13 August 2015 | By CPhI China
CPhI – a division of UBM EMEA – alongside UBM Sinexpo, announces the findings of the Pharma Insights China 2015 report.
12 August 2015 | By Sartorius
Redesigned Sartobind® membrane adsorber capsules offer higher binding capacities, reduced void volumes, less buffer consumption and lower operational costs...
12 August 2015 | By Katie Sadler, Digital Content Producer, European Pharmaceutical Review
Roche have announced positive results from the Phase II M13-982 study of venetoclax, an investigational medicine developed for hard-to-treat chronic lymphocytic leukaemia.
12 August 2015 | By Quotient Clinical
Quotient Clinical, the Translational Pharmaceutics® Company, has announced that Dr Peter Scholes, its Chief Scientific Officer, has been awarded an honorary professorship in the School of Pharmacy at the University of Nottingham...
12 August 2015 | By Katie Sadler, Digital Content Producer, European Pharmaceutical Review
A magnetic blood filtering device is under development by start-up company MediSieve to capture and remove red blood cells infected with drug resistant malaria.
11 August 2015 | By Radwag
Professional level of weighing, the highest measurement accuracy...
11 August 2015 | By RADWAG
Introducing the X2 series balances from RADWAG featuring the latest generation capacitive display providing maximum comfort of use...
11 August 2015 | By Katie Sadler, Digital Content Producer, European Pharmaceutical Review
AstraZeneca today announced that MedImmune, its global biologics research and development arm, has entered into a license agreement and collaboration with Inovio Pharmaceuticals, a biotechnology company developing DNA-based immunotherapies for cancer and infectious diseases.
11 August 2015 | By Bruker
High-speed confocal system provides most quantitative and flexible live-cell imaging...
11 August 2015 | By Katie Sadler, Digital Content Producer, European Pharmaceutical Review
DKSH, the Market Expansion Services provider with a focus on Asia, and Actelion Pharmaceuticals Singapore PTE Ltd, an affiliate of Actelion Ltd, a global biopharmaceutical company, have started a collaboration to support the business growth in Asia.